Speaker Profile
Ph.D., CSO, Pathos AI
Biography
Eric Schadt is a wellknown American scientist who is recognized for his work in the fields of genomics, integrative biology, and personalized medicine. He has helped build and found companies to advance driving precision medicine into the standard of care, including founding roles at Sema4 (now GeneDx) and Sage Bionetworks, and leadership roles at Rosetta Inpharmatics, Merck, and Pacific Biosciences.Currenly, Schadt is helping build Pathos, an information driven precision oncology company, and also maintains a faculty role at the Icahn School of Medicine at Mount Sinai, where he previously led the Department of Genetics and Genomic Sciences and founded the Icahn Institute for Genomics and Multiscale Biology. Schadt has published over 500 scientific papers (hindex = 148 and has received numerous awards for his contributions to the field of genomics, including several appearances on the Reuters "most influential scientists" list.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair:
- William Oh, Mount Sinai
Patient-centric data – Real-World Evidence (RWE) and Real-World Data (RWD) - is becoming instrumental in the drug development process and for health care decisions in general. This data is not only informative for the process from discovery to new indications, clinical trial design, and drug development, it also can be of value to monitor post-marketing drug safety and for decision support in clinical practice. As the data becomes a decision driver, science companies and medical organizations are increasingly focused on leveraging RWD and RWE to not only better understand the patient populations using their drugs and the respective outcomes, but also to accelerate clinical decision support. This session will focus on the various aspects of integrating RWE and RWD to support drug development and clinical decision support.
Sessions:
- PMWC 2024 Award Ceremony
Pioneer Honoree: Atul Butte, UCSF
- Fostering Collaboration: Strategies to Enhance Data Sharing in Medical Research (PANEL)
Chair: Craig Eagle, Guardant Health
- Paul Boutros, UCLA
- Atul Butte, UCSF
- George Sledge, Caris Life Sciences
- Erica Galvez, Manifest MedEx - Regulatory Challenges in Collecting and Using Race and Ethnicity Data in Real-World Evidence
Chair: Susan Winkler, Reagan-Udall Center
- Multi-Modal Datasets & RWE/D: Pioneering Tools for Accelerated Biomedical Research
Chair: TBA
- Data Privacy and Security in RWE/D
Chair: Deven McGraw, Invitae
- Christopher Boone, AbbVie
- Susan Stayn, Stanford
- Alexa Berk King, CVS
- Accelerating Drug Development Approvals Using RWE/D (PANEL)
Chair: Maria Karasarides, BMS
- Leo Russo, Pfizer
- Eric Schadt, Ethos AI
- Ashley Brenton, Optum
